Grey Wolf Animal Health Company Description
Grey Wolf Animal Health Corp. operates as an animal health and wellness company in Canada.
The company operates in two segments, Animal Health Business Unit and Pharmacy Business Unit. It engages in the sale, marketing, and distribution of pharmaceutical, nutraceutical, and consumable products to veterinary clinics, as well as offers pharmaceuticals for the human and animal health markets.
The company provides dexmedetomidine hydrochloride oromucosal gel under the SILEO name; sedative analgesic and reversing agents for companion animals under the SEDAJECT and ATAJECT names; prescription drugs under the THYRO-TABS CANINE name; and wound care products, including medical tubes, viscose net dressings, alginate dressing, absorbent foam dressing, superabsorbent dressing, cohesive bandages, and silicone perforated tapes, as well as medical pet shirt protective wear products, such as pet shirt, pets boot, head cover, and leg sleeves.
It also offers disposables comprising syringes, needles, and IV catheters; and nutraceuticals, as well as equine health products.
The company is headquartered in Toronto, Canada.
Country | Canada |
Industry | Personal Services |
Sector | Consumer Discretionary |
CEO | Angela Cechetto |
Contact Details
Address: Bay Adelaide – West Tower Toronto, Ontario M5H 2R2 Canada | |
Website | greywolfah.com |
Stock Details
Ticker Symbol | WOLF |
Exchange | TSX Venture Exchange |
Fiscal Year | January - December |
Reporting Currency | CAD |
SIC Code | 5912 |
Key Executives
Name | Position |
---|---|
Angela Cechetto | Chief Executive Officer and Secretary |
Dr. Ian Sandler | Founder, Chief Veterinary Medical Officer and Director |
Kevin S. Palmer C.A., CPA, M.B.A. | Chief Financial Officer |
Brandon Mair-Wren | Vice President of Operations |